J A Lowe - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

J A Lowe

Showing results (61-70 of 88) with videos related to

Pageof 9

Sort By:

Bulletin of Environmental Contamination and Toxicology|September 1, 1982

A study of well water in selected California communities for residues of 1,3-dichloropropene, chloroallyl alcohol and 49 organophosphate or chlorinated hydrocarbon pesticidesK T Maddy, H R Fong, J A Lowe, et al.

Nature|March 25, 1993

Different binding epitopes on the NK1 receptor for substance P and non-peptide antagonistU Gether, T E Johansen, R M Snider, et al.

Regulatory Peptides|July 2, 1993

Antiinflammatory and analgesic activity of CP-96,345: an orally active non-peptide substance P receptor antagonistA Nagahisa, Y Kanai, O Suga, et al.

European Journal of Pharmacology|July 7, 1992

Antiinflammatory and analgesic activity of a non-peptide substance P receptor antagonistA Nagahisa, Y Kanai, O Suga, et al.

Immunology|November 1, 1986

Immunogenic and antigenic epitopes of immunoglobulins. XVIII. Subpopulations of human lambda chains defined with a panel of monoclonal antibodiesM R Walker, A Solomon, N R Ling, et al.

Molecular Pharmacology|May 1, 1996

Photoaffinity labeling of the human substance P (neurokinin-1) receptor with [3H2]azido-CP-96,345, a photoreactive derivative of a nonpeptide antagonistD MacDonald, S C Silberman, J A Lowe, et al.

The Journal of Biological Chemistry|August 22, 1997

Characterization of non-peptide antagonist and peptide agonist binding sites of the NK1 receptor with fluorescent ligandsG Turcatti, S Zoffmann, J A Lowe, et al.

European Journal of Pharmacology|November 10, 1992

CP-96,345 antagonism of NK1 receptors and smoke-induced protein extravasation in relation to its cardiovascular effectsP Delay-Goyet, A Franco-Cereceda, S F Gonsalves, et al.

Pediatrics|March 2, 1999

The scope of unmet maternal health needs in pediatric settingsR S Kahn, P H Wise, J A Finkelstein, et al.

The Journal of Pharmacology and Experimental Therapeutics|April 1, 1997

Cardiovascular effects of cholecystokinin-4 are mediated by the cholecystokinin-B receptor subtype in the conscious guinea pig and dogA A Fossa, M J DePasquale, J Morrone, et al.

Pageof 9

Search research articles

Showing results (61-70 of 88) with videos related to

Sort By:

Pageof 9

Bulletin of Environmental Contamination and Toxicology|September 1, 1982

Nature|March 25, 1993

Different binding epitopes on the NK1 receptor for substance P and non-peptide antagonistU Gether, T E Johansen, R M Snider, et al.

Regulatory Peptides|July 2, 1993

Antiinflammatory and analgesic activity of CP-96,345: an orally active non-peptide substance P receptor antagonistA Nagahisa, Y Kanai, O Suga, et al.

European Journal of Pharmacology|July 7, 1992

Antiinflammatory and analgesic activity of a non-peptide substance P receptor antagonistA Nagahisa, Y Kanai, O Suga, et al.

Immunology|November 1, 1986

Immunogenic and antigenic epitopes of immunoglobulins. XVIII. Subpopulations of human lambda chains defined with a panel of monoclonal antibodiesM R Walker, A Solomon, N R Ling, et al.

Molecular Pharmacology|May 1, 1996

Photoaffinity labeling of the human substance P (neurokinin-1) receptor with [3H2]azido-CP-96,345, a photoreactive derivative of a nonpeptide antagonistD MacDonald, S C Silberman, J A Lowe, et al.

The Journal of Biological Chemistry|August 22, 1997

Characterization of non-peptide antagonist and peptide agonist binding sites of the NK1 receptor with fluorescent ligandsG Turcatti, S Zoffmann, J A Lowe, et al.

European Journal of Pharmacology|November 10, 1992

CP-96,345 antagonism of NK1 receptors and smoke-induced protein extravasation in relation to its cardiovascular effectsP Delay-Goyet, A Franco-Cereceda, S F Gonsalves, et al.

Pediatrics|March 2, 1999

The scope of unmet maternal health needs in pediatric settingsR S Kahn, P H Wise, J A Finkelstein, et al.

The Journal of Pharmacology and Experimental Therapeutics|April 1, 1997

Cardiovascular effects of cholecystokinin-4 are mediated by the cholecystokinin-B receptor subtype in the conscious guinea pig and dogA A Fossa, M J DePasquale, J Morrone, et al.

Pageof 9